GlassScriptPhysician profile
Madhu Nair
NPI 1083877039
$2,113.13
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,483 · 2020: $630.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $415.93 | 2019-2020 | |
| Insmed, INC. | $296.27 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $248.03 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $215.63 | 2019-2020 | |
| Grifols USA, LLC | $139.72 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $96.67 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $88.34 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.65 | 2019 | |
| Genzyme Corporation | $64.27 | 2019-2020 | |
| Philips North America LLC | $53.38 | 2019 | |
| Allergan, INC. | $49.50 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $46.54 | 2019-2020 | |
| Masimo Corporation | $43.22 | 2020 | |
| Portola Pharmaceuticals, LLC | $40.74 | 2019 | |
| Mallinckrodt Enterprises LLC | $40.69 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $38.77 | 2019 | |
| Janssen Pharmaceuticals, INC | $38.76 | 2019-2020 | |
| Resmed Corp | $36.30 | 2019-2020 | |
| Circassia INC. | $29.71 | 2019 | |
| Mylan Specialty L.P. | $23.14 | 2019-2020 | |
| Advanced Respiratory, INC | $13.38 | 2019 | |
| Pfizer INC. | $12.49 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madhu Nair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.